Navigation Links
Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
Date:5/14/2012

ANN ARBOR, Mich., May 14, 2012 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE Amex: SYN), a developer of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses, announced today the appointment of Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs. In this position, Dr. Reed will be responsible for the design and implementation of all aspects of clinical development, including clinical trials, and will lead the Company's regulatory initiatives. Dr. Reed brings over 25 years of experience, in medical practice and in the biotechnology/pharmaceutical sector, including six years with Clinical Data, Inc., a publicly-traded biopharmaceutical company which was acquired by Forest Laboratories, Inc.

Most recently, Dr. Reed served as Chief Medical Officer at Clinical Data, Inc. from 2005 through 2011, after the company merged with Genaissance Pharmaceuticals, Inc., where she had served as Vice President, Medical Affairs since 2003. During her tenure at Clinical Data, Inc., Dr. Reed was responsible for the design and management of two successful consecutive Phase III clinical trials for VIIBRYD® which is used in the treatment of major depressive disorder in adults. These efforts led to the approval of VIIBRYD in January 2011 by the U.S. Food and Drug Administration. Prior to this time, Dr. Reed served as Associate Medical Director in Pulmonary Medical Research at Bayer Pharmaceuticals, Inc. Previously, she was the Associate Director, Section of Pulmonary and Critical Care Medicine at the Hospital of St. Raphael and directed its Medical Intensive Care Unit.

"We are very pleased to add an executive of Carol's caliber to the Synthetic Biologics' team. Carol's broad experience in clinical development, as well as her leadership skills, are expected to be tremendous assets to the Company as we continue to
'/>"/>

SOURCE Synthetic Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Stemline Therapeutics Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association of Cancer Research (AACR)
3. Adeona Announces Executive Management Transitions and Board of Directors Appointments to Strengthen Companys Synthetic Biologics Strategic Focus
4. Synthetic Genomics, Inc. and Integrated DNA Technologies, Inc. Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
5. Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
6. Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
7. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
8. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
9. Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Novus Scientific Announces the Worlds 1st Long-Term Absorbable Mesh as an Alternative to Non-Absorbable Synthetic Mesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma Victims ... victims of mesothelioma get the best possible compensation, ... individuals with this rare cancer caused by exposure ... up-to-date information related to treatment options such as ... call the Mesothelioma Victims Center anytime at 866-714-6466. ...
(Date:5/22/2015)... 22, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... systems ("EPS"), today announced that its CGuard TM Embolic ... investigator Prof. Piotr Musialek , at the EuroPCR ... France . PARADIGM, an investigator-initiated P ... A roti D revascularization I n symptomatic and ...
(Date:5/22/2015)... May 22, 2015  In a sweeping analysis assessing ... T1D Exchange researchers conclude that there remains ... diabetes across all age groups, but especially for adolescents ... picture of diabetes treatment, underscoring the need to address ... that can help type 1 patients achieve optimal metabolic ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... TAMPA, Fla., April 23, 2007 /PRNewswire/ -- Sirion ... Company's pipeline,compounds, ST-601 (difluprednate) and ST-602 (fenretinide), will ... Association for,Research in Vision and Ophthalmology (ARVO) in ... company will be hosting a,reception for ARVO attendees. ...
... Analyses To Be Presented --, SAN FRANCISCO, April 24, ... the Company's Phase,2 efficacy study of Dimebon(TM) in Alzheimer's ... United States at the American,Academy of Neurology's 59th Annual ... Eastern time. The presentation will include new,data from both ...
Cached Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized ... power learned through meditation and initiation at Special Holistic ... , Yogamaatha, a nine-year-old girl from North Carolina, stunned ... attending the 2015 Business Advocacy Summit at Capitol Hill ... , In a demonstration that lasted three hours, Yogamaatha ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 With the ... businesses, are finding it increasingly difficult to provide their ... fail to provide adequate insurance for employees stand to ... been such an integral part of a business’s success ... healthcare for businesses, Online USA Doctors has created a ...
(Date:5/23/2015)... CO (PRWEB) May 23, 2015 On May ... in MuckFest. The event was a 5k mud obstacle run ... more than 2 million people worldwide, and the reason we ... community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred ... Multiple Sclerosis Society.” , The event was not only attended ...
(Date:5/23/2015)... A live auction will be held to sell over 5,200 ... medical facilities around the United States. Various types of ... exam and much more. , The live auction will ... at 9:00am CDT each day. The equipment is at their ... IL 60160. Anyone can participate in the auction including ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ... as simple as dragging and dropping footage into the FCPX ... effect. , Including over 80 stunning flares, ProFlare 5K ... this the ultimate bundle for adding prismatic refractions to any ... are movie files designed for Final Cut Pro X, but ...
Breaking Medicine News(10 mins):Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2
... Theurer Cancer Center at Hackensack University Medical Center announced ... in the tri-state area currently implanting a wireless radiation ... Cancer Center radiation oncologists can now receive data immediately ... delivered to tumors and surrounding tissue for prostate cancer ...
... ... accessible and valuable , ... Newton, MA (PRWEB) May 17, 2010 -- Microfluidics (OTCBB: MFLU), ... formal collaboration program to further promote the use of nanotechnology in scientific research ...
... ... industry news to keep Affiliates informed on how to achieve the highest conversion performance. ... Encino, CA ... forerunner in innovative technology concerning the affiliate marketing industry. Founded in 2006, T3Leads has ...
... ... workers, compensation and liability markets, announced that it has received notification from the Centers ... Set-Asides (MSA). , ... Tampa, Florida (Vocus) May 17, 2010 -- PMSI Settlement Solutions , a leading ...
... ... more are exposed to dangerous levels of noise each day. But, while noise-induced hearing loss ... ... Better Hearing Month, but millions of Americans are continuing to needlessly risk losing their ...
... ATS 2010, NEW ORLEANS You expect to find leading ... sleep medicine presenting their research at the annual ATS ... certainly. High school students? Not so much. ... April and will graduate from high school on May ...
Cached Medicine News:Health News:John Theurer Cancer Center offers breakthrough radiation measurement technology 2Health News:Microfluidics Promotes Scientific University Research Using Nanotechnology with Innovation Incentives 2Health News:Microfluidics Promotes Scientific University Research Using Nanotechnology with Innovation Incentives 3Health News:Microfluidics Promotes Scientific University Research Using Nanotechnology with Innovation Incentives 4Health News:T3Leads Provides Latest Industry News: Imperative Information to Help Publishers Maximize Profits 2Health News:T3Leads Provides Latest Industry News: Imperative Information to Help Publishers Maximize Profits 3Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 2Health News:PMSI Advocacy Efforts Prompt CMS to Improve MSA Review Methodology 3Health News:Millions Are Losing Their Hearing Unnecessarily; Noise-Induced Hearing Loss Is Always Preventable, Says HearUSA Audiologist 2Health News:Millions Are Losing Their Hearing Unnecessarily; Noise-Induced Hearing Loss Is Always Preventable, Says HearUSA Audiologist 3Health News:Challenging the use of routine repeated chest X-rays in certain patients 2Health News:Challenging the use of routine repeated chest X-rays in certain patients 3
Rubber bronchial catheter with thumb valve, one eye, coude whistle tip, with pop-up solution container, two vinyl gloves in peel-open package....
Gentle-Flo® Standard Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
Sterile Straight Packed TOUCH-TROL Suction Catheters...
Sterile Straight Packed TOUCH-TROL Suction Catheters...
Medicine Products: